Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Rockwell Collins Sets Up JV With AVIC LETRI In China - Quick Facts

Rockwell Collins (COL: Quote) said it established joint venture AVIC Leihua Rockwell Collins Avionics Co. with China Leihua Electronic Technology Research Institute, or LETRI, a unit of the Aviation Industry Corp. of China, or AVIC.

The joint venture will focus on bringing the latest surveillance products to the Commercial Aircraft Corporation of China Ltd. C919 aircraft.

Once the agreement conditions have been satisfied and approval by the Peoples Republic of China examination and approval authorities is obtained, AVIC Leihua Rockwell Collins Avionics Co. will develop, manufacture and deliver integrated surveillance system products for the C919 program in China. By introducing Rockwell Collins' advanced avionics technology and international avionics technical services into China, the joint venture will boost the development and prosperity of the country's commercial aviation sector.

Click here to receive FREE breaking news email alerts for Rockwell Collins and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A Thai company has bought iconic U.S. tuna brand Bumble Bee for $1.51 billion dollars. Thai Union Frozen Products Public Company Limited or TUF, the world's largest processor of shelf-stable tuna products snapped up Bumble Bee from private equity firm Lion Capital. Post Synergies, the transaction... Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.